ALLOPHARM is a biotechnology company

Established in 2004 with the support of the Foundation for the Promotion of Innovation

Studying insect immune systems as the basis of scientific discoveries

The creation of technologies for the introduction of newly acquired knowledge into modern medicine

Cooperation with Russian and foreign institutions in the field of developing new methods of treatment and disease prevention

Pull the arrow button to the side



The Allopharm Scientific Group took part in the development, clinical trials and promotion of the alloferon-based antiviral drug Allokin-Alfa (author Chernysh SI). Allokin-alpha is the only injection in the world based on components of insect immune systems.

Our team